HKU has joined a global effort to develop a vaccine candidate against COVID-19, led the Coalition for Epidemic Preparedness Innovations (CEPI). The HKU effort is led by the university’s State Key Laboratory for Emerging Infectious Diseases (SKL).
Launched at Davos in 2017, CEPI is a partnership between public, private, philanthropic, and civil organisations in a joint effort to develop vaccines to stop future epidemics. Established in 2005, SKL has played a key role in supporting Hong Kong’s response to several outbreaks of infectious diseases, including the current COVID-19. Professor Yuen Kwok-yong, of the Department of Microbiology, serves as a co-director of the lab.
SKL is the latest research lab to join CEPI to develop a COVID-19 vaccine. Currently there are seven COVID-19 vaccines in development by different expert teams around the world. The HKU team is led by Professor Honglin Chen, along with team members Professor Zhiwei Chen, Professor Yiwu He and Professor Yuen.